Longitudinal association between sleep features and refractive errors in preschoolers from the EDEN birth-cohort.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 04 2021
Historique:
received: 18 12 2020
accepted: 13 04 2021
entrez: 28 4 2021
pubmed: 29 4 2021
medline: 15 10 2021
Statut: epublish

Résumé

Refractive errors are common, especially in children and adolescents, leading to global health issues, academic implications and economic costs. Circadian rhythm and sleep habits may play a role. The study included 1130 children from the EDEN birth-cohort. Data were collected through parental questionnaires at age 2 and 5 for sleep duration and timing, and at age 5 for refractive error. At 5 years, 20.4% were prescribed glasses (2% for myopia, 11.9% for hyperopia and 6.8% for unknown reason). Children slept on average (SD) 11h05/night (± 30 min) and 10h49/night (± 48 min) at age 2 and 5, respectively. Average bedtime and midsleep was 8.36 pm (± 30 min), 2.06 am (± 36 min), and 8.54 pm (± 30 min), 2.06 am (± 24 min) at age 2 and 5, respectively. A U-shaped association was observed between sleep duration at age 2 and eyeglass prescription at age 5. Later midsleep and bedtime at age 2 were associated with an increased risk of eyeglass prescription at age 5. Associations became borderline significant after adjustment for confounding factors. Sleep duration and timing at age 2 were associated with subsequent refractive errors in preschoolers from general population. Sleep hygiene might be a target for refractive errors prevention.

Identifiants

pubmed: 33907290
doi: 10.1038/s41598-021-88756-w
pii: 10.1038/s41598-021-88756-w
pmc: PMC8079679
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9044

Références

Invest Ophthalmol Vis Sci. 2001 Mar;42(3):584-8
pubmed: 11222514
Chronobiol Int. 2006;23(1-2):497-509
pubmed: 16687322
Invest Ophthalmol Vis Sci. 2000 May;41(6):1249-58
pubmed: 10798638
Clin Ophthalmol. 2020 Apr 22;14:1079-1090
pubmed: 32368006
Prog Retin Eye Res. 2017 Nov;61:60-71
pubmed: 28602573
Nature. 2000 Mar 9;404(6774):143-4
pubmed: 10724157
J Pineal Res. 2001 Sep;31(2):145-54
pubmed: 11555170
Curr Biol. 2004 Dec 29;14(24):R1038-9
pubmed: 15620633
Cochrane Database Syst Rev. 2020 Jan 13;1:CD004916
pubmed: 31930781
Arch Ophthalmol. 2002 May;120(5):620-7
pubmed: 12003612
Invest Ophthalmol Vis Sci. 2011 Jul 11;52(8):5121-9
pubmed: 21571673
Invest Ophthalmol Vis Sci. 1987 Aug;28(8):1225-35
pubmed: 3610540
Br J Ophthalmol. 2003 May;87(5):580-2
pubmed: 12714399
BMC Ophthalmol. 2014 Dec 23;14:163
pubmed: 25539893
PLoS One. 2015 Mar 26;10(3):e0121796
pubmed: 25811755
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):882-9
pubmed: 19684006
Percept Mot Skills. 2001 Jun;92(3 Pt 1):640-2
pubmed: 11453186
Neuron. 2004 Aug 19;43(4):447-68
pubmed: 15312645
Invest Ophthalmol Vis Sci. 2012 Sep 14;53(10):6245-53
pubmed: 22893678
Med Sci Monit. 2004 Apr;10(4):CR168-71
pubmed: 15039648
Nature. 2000 Mar 9;404(6774):144
pubmed: 10724158
Ann Acad Med Stetin. 2004;50(2):51-4
pubmed: 16529165
J Physiol. 2003 Jun 15;549(Pt 3):945-52
pubmed: 12717008
Lancet. 2012 May 5;379(9827):1739-48
pubmed: 22559900
J Pineal Res. 2019 May;66(4):e12562
pubmed: 30697806
Exp Eye Res. 2013 Sep;114:106-19
pubmed: 23434455
Ophthalmic Physiol Opt. 2018 May;38(3):217-245
pubmed: 29691928
Invest Ophthalmol Vis Sci. 2012 Jul 01;53(8):4363-70
pubmed: 22669720
Proc Natl Acad Sci U S A. 2011 Sep 13;108 Suppl 3:15602-8
pubmed: 21536890
Nature. 1999 May 13;399(6732):113-4
pubmed: 10335839
EBioMedicine. 2017 Feb;15:210-219
pubmed: 28063778
Invest Ophthalmol Vis Sci. 2001 May;42(6):1146-52
pubmed: 11328720
J Clin Sleep Med. 2016 Jun 15;12(6):785-6
pubmed: 27250809
Mol Autism. 2018 Mar 27;9:22
pubmed: 29610657
Vis Neurosci. 2005 May-Jun;22(3):251-61
pubmed: 16079001
Exp Eye Res. 2013 Sep;114:25-34
pubmed: 23298452
Nat Genet. 2020 Apr;52(4):401-407
pubmed: 32231278
Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2237-2247
pubmed: 31112608
Vision Res. 1995 May;35(9):1195-202
pubmed: 7610580
J Sleep Res. 2004 Sep;13(3):265-8
pubmed: 15339262
Sleep Med. 2013 Dec;14(12):1283-9
pubmed: 24269649
Ophthalmic Physiol Opt. 2019 Sep;39(5):358-369
pubmed: 31332822
J Sleep Res. 2014 Aug;23(4):397-405
pubmed: 24628737
Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3692-7
pubmed: 12882825
Sci Rep. 2016 Sep 21;6:33902
pubmed: 27650408
BMC Ophthalmol. 2014 Oct 01;14:115
pubmed: 25274449
Acta Ophthalmol. 2016 May;94(3):e204-10
pubmed: 26031352
Sci Rep. 2020 Oct 14;10(1):17194
pubmed: 33057123
Front Neurosci. 2019 Mar 05;13:126
pubmed: 30890907
Eye (Lond). 1992;6 ( Pt 2):154-60
pubmed: 1624037
Int J Epidemiol. 2016 Apr;45(2):353-63
pubmed: 26283636
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2519-28
pubmed: 12147579
NPJ Aging Mech Dis. 2017 Jun 16;3:9
pubmed: 28649427
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):37
pubmed: 32196099

Auteurs

Alexis Rayapoullé (A)

CRESS, Inserm, INRAE, Université de Paris, 75004, Paris, France.
Hôpitaux de Paris, 3 rue Victoria, 75004, Paris, France.

Claude Gronfier (C)

Lyon Neuroscience Research Center (CRNL), Waking Team, Inserm UMRS 1028, CNRS UMR 5292, Université Claude Bernard Lyon 1, Université de Lyon, 69000, Lyon, France.

Anne Forhan (A)

CRESS, Inserm, INRAE, Université de Paris, 75004, Paris, France.

Barbara Heude (B)

CRESS, Inserm, INRAE, Université de Paris, 75004, Paris, France.

Marie-Aline Charles (MA)

CRESS, Inserm, INRAE, Université de Paris, 75004, Paris, France.

Sabine Plancoulaine (S)

CRESS, Inserm, INRAE, Université de Paris, 75004, Paris, France. sabine.plancoulaine@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH